Cytokine Blood Filtration Responses in COVID-19.


Journal

Blood purification
ISSN: 1421-9735
Titre abrégé: Blood Purif
Pays: Switzerland
ID NLM: 8402040

Informations de publication

Date de publication:
2021
Historique:
received: 02 04 2020
accepted: 28 04 2020
pubmed: 29 5 2020
medline: 5 3 2021
entrez: 29 5 2020
Statut: ppublish

Résumé

The real issue with the COVID-19 pandemic is that a rapidly increasing number of patients with life-threatening complications are admitted in hospitals and are not well-administered. Although a limited number of patients use the intensive care unit (ICU), they consume medical resources, safety equipment, and enormous equipment with little possibility of rapid recovery and ICU discharge. This work reviews effective methods of using filtration devices in treatment to reduce the level of various inflammatory mediators and discharge patients from the ICU faster. Extracorporeal technologies have been reviewed as a medical approach to absorb cytokines. Although these devices do not kill or remove the virus, they are a promising solution for treating patients and their faster removal from the ICU, thus relieving the bottleneck.

Identifiants

pubmed: 32464624
pii: 000508278
doi: 10.1159/000508278
pmc: PMC7490911
doi:

Substances chimiques

Anti-Bacterial Agents 0
Coated Materials, Biocompatible 0
Cytokines 0
Membranes, Artificial 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-149

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Khaled Al Shareef (K)

Department of Medical Equipment Technology, College of Applied Medical Science, Majmaah University, Majmaah, Saudi Arabia.

Mohsen Bakouri (M)

Department of Medical Equipment Technology, College of Applied Medical Science, Majmaah University, Majmaah, Saudi Arabia, m.bakouri@mu.edu.sa.
Department of Physics, College of Arts, Sebha University, Traghen, Libya, m.bakouri@mu.edu.sa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH